Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
11.06
+0.24 (2.22%)
At close: Feb 11, 2026, 4:00 PM EST
11.07
+0.01 (0.09%)
After-hours: Feb 11, 2026, 4:32 PM EST
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $396.99 million as of February 11, 2026. Its market cap has decreased by -14.93% in one year.
Market Cap
396.99M
Enterprise Value
122.55M
1-Year Change
-14.93%
Ranking
Category
Stock Price
$11.06
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $396.99M, an increase of 58.15%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 388.02M | 5.25% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 399.24M |
| NovaBridge Biosciences | 395.45M |
| Benitec Biopharma | 385.71M |
| Absci | 384.95M |
| Greenwich LifeSciences | 377.54M |
| PepGen | 376.74M |
| Monopar Therapeutics | 376.63M |
| Bicycle Therapeutics | 375.97M |